Hengrui Medicine Co., Ltd. (01276.HK): Injection SHR-1501 included in the list of proposed breakthrough therapies.

Zhtng Cijng APP news, Hansoh Pharmaceutical (01276.HK) announced that its subsidiary Shanghai Hansoh Pharmaceutical Co., Ltd.'s injection SHR-1501 has been included in the list of proposed breakthrough therapeutic varieties by the National Medical Products Administration Drug Evaluation Center ("Drug Evaluation Center"), with a 7-day public notification period.